COMPARATIVE EFFECTIVENESS OF BIOCHEMICAL, ELISA, AND FIBROSCAN METHODS IN THE PREVENTION AND MONITORING OF AUTOIMMUNE HEPATITIS
Keywords:
Keywords: autoimmune hepatitis; FibroScan; ELISA; liver fibrosis; autoimmune antibodies; biochemical markers; liver monitoring; hepatic inflammation .Abstract
Autoimmune hepatitis is a chronic inflammatory liver disease associated with progressive fibrosis and liver dysfunction. This study evaluated the comparative effectiveness of biochemical, ELISA, and FibroScan methods in the prevention and monitoring of autoimmune hepatitis. A retrospective observational study involving 3 patients diagnosed between January and May 2026 was conducted. Biochemical liver tests, ELISA-based autoimmune antibody analysis, and FibroScan liver stiffness assessment were performed. Elevated ALT, AST, and IgG levels were identified in all patients, while positive ANA and SMA antibodies were detected in two cases. FibroScan demonstrated varying degrees of liver fibrosis. Combined diagnostic approaches improved disease monitoring and clinical evaluation.
References
1.European Association for the Study of the Liver. (2015). EASL clinical practice guidelines: Autoimmune hepatitis. Journal of Hepatology, 63(4), 971–1004. https://doi.org/10.1016/j.jhep.2015.06.030
2.Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020). Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology, 72(2), 671–722. https://doi.org/10.1002/hep.31065
3.Liberal, R., Longhi, M. S., Mieli-Vergani, G., & Vergani, D. (2013). Pathogenesis of autoimmune hepatitis. Best Practice & Research Clinical Gastroenterology, 25(6), 653–664. https://doi.org/10.1016/j.bpg.2011.11.009
4.Czaja, A. J. (2014). Autoimmune hepatitis: Current management and future directions. Gut and Liver, 10(2), 177–203. https://doi.org/10.5009/gnl14352